← Back to Patent Explorer
US4622430A Expired / Lapsed US ⏱️ 0.0 years remaining

Derivatives of pentacyclo undecanes, processes for preparing these compounds, and pharmaceutical compositions thereof

Assignee: NORIDATA Ltd
•
Filing: 1982-12-21
•
Granted: 1986-11-11
•
Expires: 2002-12-21
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Pentacyclo[6.3.0.0. 2 ,6.0 3 ,10.0 5 ,9 ]undecane and its derivatives are prepared. The compounds find use as antiviral agents.

Inventors

  • 👤 Theodor G. Dekker
  • 👤 Douglas W. Oliver
  • 👤 Friedrich O. Snyckers
  • 👤 Cornelis J. van der Schyf

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 08:14
CPC Classifications
C; C07; C07C; C07C211/00; C07C211/33; C07C211/39; C07C211/41; A; A61; A61P; A61P25/00; A61P31/00; A61P31/12; C07C2603/00; C07C2603/56; C07C2603/90; C07C2603/91

Claims Analysis

Total Claims: 35
Claim 1
Independent Claim 107 words
A compound of one of the formulae: A--R.sub.1 R.sub.2 (I) A--NHR.sub.1 (II) and A--NHR.sub.4 (III) wherein A is (a) a substituted or unsubstituted (D 3 )-trishomocubane or (b) an alkyl- or aryl-substituted (D 3 )-trishomocubane, being (a) for compounds (I) and (III); R 1 is hydrogen, alkyl, aryl, halo, hydroxy, hydroxyalkyl or amino, each alkyl or aryl being optionally substituted by one or more similar or different substituents; R 2 is aryl, amino, alkoxy, aryloxy or hydroxyalkyl, each alkyl or aryl being optionally substituted by one or more similar or different substituents; R 4 is hydrogen (--H), optionally-substituted alkyl or optionally-substituted aryl; or an acid-addition salt therof.
Claim 2
Dependent Claim 107 words
A compound of one of the formulae: A--R.sub.1 R.sub.2 (I) A--NHR.sub.1 (II) and A--NHR.sub.4 (III) wherein A is (a) a substituted or unsubstituted (D 3 )-trishomocubane or (b) an alkyl- or aryl-substituted (D 3 )-trishomocubane, being (a) for compounds (I) and (III); R 1 is hydrogen, alkyl, aryl, halo, hydroxy, hydroxyalkyl or amino, each alkyl or aryl being optionally substituted by one or more similar or different substituents; R 2 is aryl, amino, alkoxy, aryloxy or hydroxyalkyl, each alkyl or aryl being optionally substituted by one or more similar or different substituents; R 4 is hydrogen (--H), optionally-substituted alkyl or optionally-substituted aryl; or an acid-addition salt therof.
Claim 3
Dependent Claim 123 words
A pharmaceutical composition useful for treating or preventing a viral infection and/or Parkinson's disease which comprises an effective amount of a pharmacologically-acceptable compound in admixture with a suitable diluent or adjuvent; wherein the pharmacologically-acceptable compound is of one of the formulae: A--R.sub.1 R.sub.2 (I) A--NHR.sub.1 (II) and A--NHR.sub.4 (III) wherein A is (a) a substituted or unsubstituted (D 3 )-trishomocubane or (b) an alkyl- or aryl-substituted (D 3 )-trishomocubane, being (a) for compounds (I) and (II); each of R 1 and R 2 is, independently, hydrogen, alkyl, aryl, halo, hydroxy, hydroxyalkyl or amino, each alkyl or aryl being optionally substituted by one or more similar or different substitutents; R 4 is hydrogen (--H), optionally-substituted alkyl or optionally-substituted aryl; or an acid-addition salt thereof.
Claim 4
Dependent Claim 123 words
A pharmaceutical composition useful for treating or preventing a viral infection and/or Parkinson's disease which comprises an effective amount of a pharmacologically-acceptable compound in admixture with a suitable diluent or adjuvent; wherein the pharmacologically-acceptable compound is of one of the formulae: A--R.sub.1 R.sub.2 (I) A--NHR.sub.1 (II) and A--NHR.sub.4 (III) wherein A is (a) a substituted or unsubstituted (D 3 )-trishomocubane or (b) an alkyl- or aryl-substituted (D 3 )-trishomocubane, being (a) for compounds (I) and (II); each of R 1 and R 2 is, independently, hydrogen, alkyl, aryl, halo, hydroxy, hydroxyalkyl or amino, each alkyl or aryl being optionally substituted by one or more similar or different substitutents; R 4 is hydrogen (--H), optionally-substituted alkyl or optionally-substituted aryl; or an acid-addition salt thereof.
Claim 5
Dependent Claim 62 words
A compound of claim 1 the general formula (II) A--NHR.sub.1 (II) wherein A is a substituted or unsubstituted (D 3 )-trishomocubane, and R 1 is hydrogen, an alkyl, aryl, halo, hydroxy, or hydroxylalkyl group, wherein each alkyl or aryl group optionally has one or more suitable substituent(s) which may be the same or different; or an acid addition salt of such compound.
Claim 6
Dependent Claim 43 words
A compound as claimed in claim 3, wherein A is a substituted (D 3 )-trishomocubane, one or more substituent(s) thereon comprising an alkyl, aryl, --OR 3 group (where R 3 is hydrogen, or an alkyl or aryl group), a halogen, or amine group.
Claim 7
Dependent Claim 66 words
A compound of claim 1 the general formula (III) A--NHR.sub.4 (III) wherein A is an unsubstituted (D 3 )-trishomocubane, or an alkyl or aryl substituted (D 3 )-trishomocubane, and R 4 is hydrogen, an alkyl, or aryl group, wherein each alkyl and/or aryl group optionally has one or more suitable substituent(s) which may be the same or different; or an acid addition salt of such compound.
Claim 8
Dependent Claim 55 words
A compound of claim 1 the structural type ##STR9## wherein each of R, R', and R" is, independently hydrogen, an alkyl, aryl, halo, hydroxy, or amine group, wherein each alkyl or aryl group optionally has one or more suitable substituent(s) which may be the same or different; or and acid addition salt of such compound.
Claim 9
Dependent Claim 27 words
A compound as claimed in claim 6, wherein R is hydrogen or an alkyl group, and each of R' and R" is an alkyl or aryl group.
Claim 10
Dependent Claim 55 words
A compound of claim 1 the structural type ##STR10## wherein each of R, R', and R" is, independently hydrogen, an alkyl, aryl, halo, hydroxy, or amine group, wherein each alkyl or aryl group optionally has one or more suitable substituent(s) which may be the same or different; or and acid addition salt of such compound.
Claim 11
Dependent Claim 27 words
A compound as claimed in claim 8, wherein R is hydrogen or an alkyl group, and each of R' and R" is an alkyl or aryl group.
Claim 12
Dependent Claim 53 words
A compound of claim 1 the structural type ##STR11## wherein each of R and R' is, independently hydrogen, alkyl, aryl, halo, hydroxy, or amine group, wherein each alkyl or aryl group optionally has one or more suitable substituents(s) which may be the same or different; or and acid addition salt of such compound.
Claim 13
Dependent Claim 22 words
Compound as claimed in claim 10, wherein R is hydrogen or an alkyl group, and R' is an alkyl or aryl group.
Claim 14
Dependent Claim 8 words
The compound of claim 1 4-amino-(D 3 )-trishomocubane.
Claim 15
Dependent Claim 8 words
The compound of claim 1 4-methylamino-(D 3 )-trishomocubane.
Claim 16
Dependent Claim 8 words
The compound of claim 1 4-amino-3-methyl-(D 3 )-trishomocubane.
Claim 17
Dependent Claim 8 words
The compound of claim 1 3-methyl-4-methylamino-(D 3 )-trishomocubane.
Claim 18
Dependent Claim 8 words
The compound of claim 1 4-ethylamino-3-methyl-(D 3 )-trishomocubane.
Claim 19
Dependent Claim 8 words
The compound of claim 1 3-ethyl-4-ethylamino-(D 3 )-trishomocubane.
Claim 20
Dependent Claim 8 words
The compound of claim 1 4-amino-3-phenyl-(D 3 )-trishomocubane.
Claim 21
Dependent Claim 8 words
The compound of claim 1 4-methylamino-3-phenyl-(D 3 )-trishomocubane.
Claim 22
Dependent Claim 8 words
The compound of claim 1 4-ethylamino-3-phenyl-(D 3 )-trishomocubane.
Claim 23
Dependent Claim 8 words
The compound of claim 1 4-butylamino-3-methyl-(D 3 )-trishomocubane.
Claim 24
Dependent Claim 8 words
The compound of claim 1 4-benzylamino-3-methyl-(D 3 )-trishomocubane.
Claim 25
Dependent Claim 8 words
The compound of claim 1 4-(β-phenylethyl)amino-3-methyl-(D 3 )-trishomocubane.
Claim 26
Dependent Claim 8 words
The compound of claim 1 4-amino-3-ethyl-(D 3 )-trishomocubane.
Claim 27
Dependent Claim 28 words
A compound of claim 1 as claimed in any one of the preceding claims, in the form of a stereo-isomer, either singly or as a mixture of isomers.
Claim 28
Dependent Claim 75 words
A compound of claim 1 the general formula (I) A--R.sub.1 R.sub.2 (I) wherein A is a substituted or unsubstituted (D 3 )-trishomocubane, and R 1 and each of R 2 is, independently, an alkyl, aryl, halo, hydroxy, hydroxyalkyl, or amine group, wherein each alkyl or aryl group optionally has one or more suitable substituents which may be the same or different or R 1 is optionally hydrogen; or an acid addition salt of such compounds.
Claim 29
Dependent Claim 43 words
A compound as claimed in claim 26, wherein A is a substituted (D 3 )-trishomocubane, one or more substituent(s) thereon comprising an alkyl, aryl, --OR 3 group (where R 3 is hydrogen, or an alkyl or aryl group), a halogen, or amine group.
Claim 30
Dependent Claim 39 words
A process for treating or preventing a viral infection and/or Parkinson's disease which comprises administering to a patient afflicted with or subject to viral infection and/or Parkinson's disease an effective amount of a composition as defined in claim 2.
Claim 31
Dependent Claim 33 words
A pharmaceutical composition according to claim 2 usefor for treating or preventing a viral infection and which comprises an effective amount of the pharmacologically-acceptable compound in admixture with a suitable diluent or adjuvant.
Claim 32
Dependent Claim 32 words
A pharmaceutical composition according to claim 2 useful for treating or preventing Parkinson's disease and which comprises an effective amount of the pharmacologically-acceptable compound in admixture with a suitable diluent or adjuvant.
Claim 33
Dependent Claim 30 words
A process for treating or preventing a viral infection which comprises administering to a patient afflicted with or subject to viral infection an effective amount of composition of claim 29.
Claim 34
Dependent Claim 29 words
A process for treating or preventing Parkinson's disease which comprises administering to a patient afflicted with or subject to Parkinson's disease an effective amount of composition of claim 30.
Claim 35
Dependent Claim 13 words
A compound according to claim 1 which is an amine or substituted amine.

References Cited (Backward Citations)

US3532741A Cited
US3536761A Cited
US3562317A Cited
US3456008A Cited
US3622628A Cited
US3641148A Cited
US3449422A Cited
EP0002896A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-11-10 1990-05-12 1990-11-11 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-11-10 1994-05-12 1994-11-11 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-11-10 1998-05-12 1998-11-11 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag